Insurance funds favor trust products. Over 100 insurance companies have investment trust balances exceeding 270 billion.Insurance funds favor trust products. Over 100 insurance companies have investment trust balances exceeding 270 billion.

Insurance funds favor trust products. Over 100 insurance companies have investment trust balances exceeding 270 billion. Original title: Insurance funds favor trust products more than stocks and funds. Over 100

Zhenhua Technology (000733) Brief Evaluation Report: Business structure continued to optimize and profitability increased significantlyZhenhua Technology (000733) Brief Evaluation Report: Business structure continued to optimize and profitability increased significantly

Zhenhua Technology (000733) Brief Evaluation Report: Business structure continued to optimize and profitability increased significantly I. Overview of the event On April 17, the company released its 2018 annual report,

Huagong Technology (000988) Annual Report Review: Revenue Steady Growth Steady Growth Strengthen R & D, High-end Products Continuously BreakthroughHuagong Technology (000988) Annual Report Review: Revenue Steady Growth Steady Growth Strengthen R & D, High-end Products Continuously Breakthrough

Huagong Technology (000988) Annual Report Review: Revenue Steady Growth Steady Growth Strengthen R & D, High-end Products Continuously Breakthrough Event: On March 29, Huagong Technology released its annual 深圳桑拿网 report.

Guangming Real Estate (600708) Annual Report Comments: Sales continue to grow steadily and actively expand into the futureGuangming Real Estate (600708) Annual Report Comments: Sales continue to grow steadily and actively expand into the future

Guangming Real Estate (600708) Annual Report Comments: Sales continue to grow steadily and actively expand into the future Core Views The company released its annual report. In 2018, it realized

Hengrui Medicine (600276) Interim Review: The research continues to increase the size of the innovation layout gradually clearHengrui Medicine (600276) Interim Review: The research continues to increase the size of the innovation layout gradually clear

Hengrui Medicine (600276) Interim Review: The research continues to increase the size of the innovation layout gradually clear Event: Hengrui Pharmaceutical released the semi-annual report for 2019, and achieved sales